Remdesivir2 by Getty ImagesULRICH PERREY/ POOL/ AFP via Getty Images

The antiviral drug remdesivir sped the recuperation of coronavirus patients in research hospitals, are consistent with a new study in the New England Journal of Medicine. The benefit showed much bigger among those who were less sick. Scientists still aren’t sure whether the medication can reduce mortality. Visit Business Insider’s homepage for more stories.

Remdesivir, the only drug cleared to treat COVID-1 9, sped the recuperation time of patients with the disease, but its benefit appeared much more limited in patients who needed mechanical ventilation as part of their therapy, according to eagerly awaited ensues of a clinical experiment.

Initial results from the study, which led to the drug’s emergency authorization by the Food and Drug Administration, were released late last month. Full data were published late Friday in the New England Journal of Medicine. See the rest of the story at Business Insider

NOW WATCH: Why the Strategic National Stockpile wasn’t prepared for the coronavirus spread

See Also 😛 TAGENDThe 40 highest-paying jobs you can get without a bachelor’s degreeCasper’s Memorial Day sale is going on now — save 15% on mattresses through May 2538 thoughtful college graduation talents for him, as therefore recommends a recent alumnu

Read more: